Committee to Hold First Hearing on Drug Company Price Increases
Washington, D.C. (Jan. 28, 2019)—On Tuesday, January, 29, 2019, the Committee on Oversight and Reform will hold its first hearing of the 116th Congress on "Examining the Actions of Drug Companies in Raising Prescription Drug Prices." WHERE: 2154 Rayburn House Office Building WHEN: Tuesday, January 29, 2019 TIME: 11:00 AM PURPOSE
BACKGROUND
WITNESSES Ms. Antroinette Worsham Mother of Two Insulin-Dependent Daughters Cincinnati, Ohio Ms. Catherine Alicia Georges, Ed.D., RN, FAAN National Volunteer President AARP Dr. Aaron Kesselheim, M.D., J.D., M.P.H. Associate Professor of Medicine Program on Regulation, Therapeutics, And Law Harvard Medical School Dr. Gerard Anderson, Ph.D. Professor of Health Policy and Management Bloomberg School of Public Health Johns Hopkins University Dr. Avik Roy President The Foundation for Research and Equal Opportunity The hearing is open to the public and a live video stream will be broadcast here. |